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Abstract
Background: Remodeling of the extracellular matrix (ECM) regulates cell adhesion as well as signaling between
cells and their microenvironment. Despite the importance of tightly regulated ECM remodeling for normal muscle
development and function, mechanisms underlying ECM remodeling in vivo remain elusive. One excellent paradigm in
which to study ECM remodeling in vivo is morphogenesis of the myotendinous junction (MTJ) during zebrafish skeletal
muscle development. During MTJ development, there are dramatic shifts in the primary components comprising the
MTJ matrix. One such shift involves the replacement of Fibronectin (Fn)-rich matrix, which is essential for both somite
and early muscle development, with laminin-rich matrix essential for normal function of the myotome. Here,
we investigate the mechanism underlying this transition.
Results: We show that laminin polymerization indirectly promotes Fn downregulation at the MTJ, via a matrix
metalloproteinase 11 (Mmp11)-dependent mechanism. Laminin deposition and organization is required for
localization of Mmp11 to the MTJ, where Mmp11 is both necessary and sufficient for Fn downregulation in
vivo. Furthermore, reduction of residual Mmp11 in laminin mutants promotes a Fn-rich MTJ that partially
rescues skeletal muscle architecture.
Conclusions: These results identify a mechanism for Fn downregulation at the MTJ, highlight crosstalk
between laminin and Fn, and identify a new in vivo function for Mmp11. Taken together, our data
demonstrate a novel signaling pathway mediating Fn downregulation. Our data revealing new regulatory
mechanisms that guide ECM remodeling during morphogenesis in vivo may inform pathological conditions
in which Fn is dysregulated.
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Background
The muscle extracellular matrix (ECM) (called the myo-
matrix) plays a critical role in muscle development, physi-
ology, homeostasis, and disease. Adhesion of muscle fibers
to their surrounding myomatrix is required for muscle
development and function, as evidenced by congenital
muscle diseases —including Duchenne, Becker, and
Merosin-deficient muscular dystrophies—which result
from mutations that disrupt adhesion of muscle fibers
to the myomatrix. The myomatrix is also critical for
muscle homeostasis because it bears much of the pas-
sive load [1, 2], and many clinical symptoms involving
range of motion and stiffness are likely derived from
changes to the myomatrix [3]. The macromolecular
composition of the myomatrix changes during muscle
development and regeneration [4–9]. These changes
in matrix composition define the biochemical and bio-
physical properties of the myomatrix; yet, the mechanisms
that mediate dynamic changes in myomatrix composition
during development and regeneration are unknown. In
this study, we focused on elucidating mechanisms that
underlie regulation of the myomatrix during development
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because this knowledge could inform efforts to maintain
muscle health and prevent muscle diseases.
Remodeling of the ECM at the nascent myotendinous
junction (MTJ) during zebrafish skeletal muscle develop-
ment provides an ideal paradigm with which to investi-
gate dynamic changes in the extracellular milieu. In
teleost fishes, the ECM-rich somite boundaries give rise
to MTJs that separate segmentally reiterated myotomes
[10]. Elegant experiments have recently provided insight
into how the ECM protein Fibronectin (Fn) is first
polymerized at somite boundaries. During somite forma-
tion, integrin alpha5 activation, clustering, and signaling
through Rap1b promote Fn polymerization [11]. Fn
polymerization is limited to nascent somite boundaries
by Eph/Ephrin signaling [12], reviewed in [13]. Subse-
quent to somitogenesis, a laminin-containing basement
membrane is enriched at MTJs and Fn is downregulated
[4, 9]. The mechanism underlying this downregulation
of Fn at MTJs is unknown.
Understanding the regulation of Fn levels in the myo-
matrix is particularly important because Fn can either
positively or negatively affect skeletal muscle depending
on the context. Fn is an interstitial matrix protein best
known for its functions during branching morphogenesis
and cell migration [14–21]. Fn is necessary for muscle
development: muscle is disorganized in zebrafish with
reduced levels of Fn [22]. Although disrupted mesoderm
development in Fn-null mice precludes analysis of how
Fn contributes to muscle organization [23], elongating
myocytes in wild-type mice express Fn receptors and ap-
pear to attach to Fn in the intersegmental ECM [4]. This
result suggests that Fn is important for mammalian
muscle development as well. Fn is also critical for
muscle regeneration: Fn in the stem cell niche is both
necessary and sufficient for satellite cell expansion [5].
These data clearly indicate that Fn is necessary for
muscle development and regeneration, perhaps by gen-
erating a supportive ECM microenvironment. However,
Fn expression in these contexts is transient. Sustained
Fn expression may contribute to pathology in aging and
diseased muscle. Abnormal Fn deposition is a hallmark
of fibrosis in cardiac and skeletal muscle [24–26]. The
replacement of contractile muscle tissue by Fn-rich fi-
brotic material leads to diminished organ function.
Therefore, it is critical to understand the mechanisms
underlying both Fn assembly and downregulation during
muscle development and regeneration.
We utilized the zebrafish MTJ, where the characteris-
tic downregulation of Fn is documented but remains
mechanistically unknown, to identify regulators of Fn
levels in vivo. We found that Fn levels are elevated in
laminin mutant embryos. This result suggests that lam-
inin deposition is a permissive cue for Fn downregula-
tion. As laminin is not known to be a protease, we
hypothesized that laminin regulates a member of the
matrix metalloproteinase (MMP) family. Collectively,
MMPs are able to cleave all known ECM proteins.
MMPs are tightly regulated during development and
homeostasis, and changes in MMP expression occur in
many diseases [27, 28]. We identified Mmp11 (also
known as stromelysin-3) as both necessary and sufficient
for Fn downregulation in vivo. Significantly, Mmp11
localization to the MTJ is regulated by laminin. Inhib-
ition of the residual Mmp11 activity in laminin mutants
increases Fn levels and improves, but does not com-
pletely rescue, muscle structure. These results suggest
that although decreased downregulation of Fn can im-
prove muscle structure, the specific biochemical and
biophysical properties of laminin are critical for normal
muscle development. Taken together, our results high-
light a novel crosstalk between myomatrix proteins and
identify a MMP that regulates Fn levels in vivo.
Methods
Zebrafish husbandry, mutant, and transgenic lines
Zebrafish embryos were collected from natural spawn-
ings of adult fish kept at 28.5 °C on a 14-h light/10-h
dark cycle and staged according to [29]. The following
strains were used: AB, Gup/laminin beta1 tg210, Sly/laminin
gamma1ti263A (a generous gift from the Tuebingen stock
center), laminin gamma1wi390Tg, and Tg(HSP:mmp11-
EGFP). All embryos were grown in embryo rearing media
(1X ERM), which contained methylene blue to prevent mi-
crobial growth. All protocols were conducted in accordance
with the University of Maine Institutional Animal Care and
Usage Committee’s guidelines, which do not require ap-
proval for the use of zebrafish 3 days old and younger.
Morpholino and transgenic construct injections
Morpholinos (MOs) were obtained from Gene Tools,
LLC (Philomath, OR, USA). All MOs were diluted in
sterile water and injected with a MPPI-2 Pressure In-
jector from ASI. Embryos were injected at the one-cell
stage in the yolk with approximately 3 nL of MO. The
nucleotide sequences of the MOs are as follows:
mmp11a MO is 5′-GAGACCCGCATCCTCCTCCTG
TATC-3′, mmp11b MO is 5′-CATGATGACGGA
GAGCCGCACGCAG-3’, and standard control MO is
5′-CCTCTTACCTCAGTTACAATTTATA-3′. Mmp11a
and mmp11b MOs were mixed, and embryos were
injected such that they received a final concentration of
approximately 2.5 ng of each MO. For controls, 12 ng of
the standard control MO was injected and did not elicit
a phenotype (data not shown). The laminin gamma1
(lamc1) MOs used have been previously described [30]
and recapitulate the mutant phenotype. The nrk2b MOs
were injected as previously described [31].
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The Tol2Kit gateway system [32] was used to create
the Tg(HSP:mmp11-EGFP) construct. The expected
product of this construct was a fusion protein of
Mmp11 and EGFP, driven by a heat shock promoter
(HSP). Primers used to create the mmp11a middle entry
vector were mmp11a F 5′-GGGGACAAGTTTGTA
CAAAAAAGCAGGCTAGCACTTCCCACTTCACTTTC
AGC-3′ and mmp11a R 5′-TCTTCGGATGTAACATGC
CAcACCCAGCTTTCTTGTACAAAGTGGTCCCC-3′.
The PCR product was recombined with the donor vec-
tor pDONR221 from the Tol2Kit via BP clonase
(Invitrogen). This plasmid was then recombined with
p5E-hsp70l, p3E-EGFPpA, and pDestTol2pA2 from the
Tol2Kit, via LR clonase (Invitrogen) to create the final
Tg(HSP:mmp11-EGFP) construct. Linearized pCS2-TP
plasmid (kindly provided by Koichi Kawakami) was
used as a template to generate capped mRNA encoding
Tol2 transposase by in vitro transcription using SP6 poly-
merase (Message Machine, Ambion). The Tg(HSP:mmp11-
EGFP) construct was co-injected with mRNA encoding
Tol2 transposase to generate transient transgenic embryos
(tTg). tTg embryos were injected at the one-cell stage into
the cell and, at the designated developmental time point,
heat-shocked at 40 °C for 1 h. A stable Tg(HSP:mmp11-
EGFP) line was also generated, and embryos collected from
natural spawnings of this line were heat-shocked as above
and used for experiments.
RNA extraction, cDNA synthesis, and quantitative PCR
RNA was extracted from whole, pooled embryos at 26
hours post fertilization (hpf ) using a RNeasy Mini Kit
(Qiagen) per manufacturer’s instructions. cDNA (500 ng
per reaction) was synthesized using BioRad’s iScript re-
agents per manufacturer’s instructions. Quantitative
PCR was performed using 300 nM of each primer per
reaction, 25 ng of cDNA per reaction, BioRad’s ssoAd-
vanced reagents, and a BioRad CFX96 C1000 Touch
real-time PCR machine per manufacturer’s instructions.
Fold changes in mRNA abundance were calculated using
the 2^(−ΔΔCt) equation. Ct values for genes of interest
were normalized to the appropriate beta-actin or gapdh
Ct values, and then values for experimental groups were
normalized to their respective controls. A value of +/− 1
indicates no change from the control level of mRNA ex-
pression. Results from 2–3 independent biological repli-
cates were averaged, and error bars represent standard
error of the mean between biological replicates. qPCR
primer sequences: beta-actin forward: 5′-TCGTGACCT
GACAGACTACCTGAT-3′; beta-actin reverse: 5′-CG
GACAATTTCTCCTTCGGCTGTG-3′; gapdh forward:
TGGGCCCATGAAAGGAAT; gapdh reverse: ACCA
GCGTCAAAGATGGATG; Fn1a forward: CCACCCA
CTGATCTGAACCT; Fn1a reverse: TCACTCTGTAG
CCCGTGATG; Fn1b forward: ATTCAACGCACGTT
CCTACC; Fn1b reverse: TAATTTTGCCCTTGCCT
GAC; lama1 forward: TGCTGGAGCTCATCAACAAC;
lama1 reverse: TTTTCCAGCACAGACACTGC; lama2
forward: GCAGAAATCCTGGATGTGGT; lama2 reverse:
TGGAGGTGGGATTCTCCATA; lamb1 forward: GCAG
CTCAAAAAGGATCTGG; lamb1 reverse: AAGTTTC
TCGCTGGCCTGTA; and lamc1 forward: GGTTGCA
AACCATGTGACTG; lamc1 reverse: CAAATTCTGC
AGGTCAAGCA.
Protein immunoblots
Protein for immunoblots was prepared from whole zeb-
rafish embryos at 23, 26, 32, or 48 hpf) using the
method described by [33]. Protein was resolved on a
10 % SDS-PAGE gel, transferred to PVDF membrane,
blocked in 5 % dry milk in phosphate buffered saline
with 0.1 % Tween20 (PBST), incubated in 1° antibody
(anti-Fibronectin 1:500, Sigma; anti-Mmp11 1:500,
Anaspec; anti-α-tubulin 1:1000, Sigma) at 4 °C over-
night. The membrane was then washed in PBST, incu-
bated in 2° antibody (anti-rabbit HRP 1:2000, Pierce;
anti-mouse HRP 1:2000, Pierce), washed, detected with
Supersignal West Dura (Pierce), and imaged on a CCD
LAS 4000 Fuji camera. Relative protein amounts were
quantified in ImageJ and normalized to loading controls
(when present).
Fixation/phalloidin staining/immunocytochemistry
Dechorionated embryos were fixed in 4 % paraformalde-
hyde (PFA) for 4 h at room temperature (RT) or over-
night at 4 °C, and fix was removed by washing five times
for 5 min each in 0.1 % PBS-Tween20.
Alexa Fluor 546 phalloidin (Molecular Probes) staining
required permeabilizing fixed embryos for 1.5 h in 2 %
PBS-Triton and then incubating in phalloidin (1:20 in
2 % PBS-Triton) for 1–4 h at RT or overnight at 4 °C.
Embryos were then deyolked and imaged, or subsequent
antibody staining was performed.
For general antibody staining, fixed embryos were
blocked for at least 1 h at RT and incubated overnight at
4 °C in primary antibody (polyclonal anti-laminin-111
1:50 (Sigma); polyclonal anti-Fibronectin generated
against human Fn 1:50 (Sigma); anti-F59 1:10 (DSHB);
anti-β-dystroglycan 1:50). All antibodies were diluted in
block (5 % w/v bovine serum albumin (BSA) in PBS with
0.1 % Tween20). Embryos were washed at RT 2–4 h in
block then incubated in secondary antibody overnight at
4 °C or for 4 h at RT (Alexa-Flour 488, 546, 633 con-
jugated goat anti-mouse or goat anti-rabbit secondary
antibodies 1:200 (Invitrogen)). Embryos were then
washed for 1 h in 0.1 % PBS-Tween20.
Anti-Mmp11 antibody staining involved fixing em-
bryos overnight at 4 °C in Dent’s fixative (80 % MeOH,
20 % DMSO). Embryos were then washed three times
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for 15 min each in PBS with 0.1 % Tween20, blocked for
4 h at RT, and incubated in an antibody raised against
zebrafish Mmp11 antigen (Anaspec, 1:50) overnight at
4 °C. Embryos were washed three times for 15 min each
and then incubated in goat anti-rabbit secondary (Invi-
trogen, 1:200) overnight at 4 °C. Embryos were washed,
deyolked, mounted, and imaged.
Imaging
Brightfield images of live embryos were taken on the
Zeiss SteREO Discovery V12 microscope at ×25 or the
Zeiss Axio Imager Z1 microscope with the ×5 objective.
Live embryos were anesthetized using a non-lethal dose
of MS-222. Fixed embryos were deyolked in PBS, side-
mounted in 80 % glycerol/20 % PBS, and imaged with
the ×20 objective of a Zeiss Axio Imager Z1 microscope
with a Zeiss ApoTome attachment and optimized by
averaging five frames. For images where fluorescence
levels were to be compared, exposure times were kept
constant throughout the imaging of that experiment. All
image modifications were performed in Adobe Photo-
shop with Gaussian filtering (0.3 pixel) and unsharp
mask (50 %, 1 pixel) prior to being collated in Adobe
Illustrator.
Histograms
Images were imported into ImageJ software, and the
intensity profiles were plotted. The resulting data were
analyzed statistically using Microsoft Office Excel soft-
ware. We calculated the maximum intensity, and all
values were normalized to it. The percentage of max-
imum intensity was plotted.
Results
Reciprocal expression of laminin and Fn at the fast-twitch
muscle MTJ during muscle development
During axial skeletal muscle development, somites
(blocks of mesodermal cells) transform into myotomes
(groups of muscle fibers). Initially short myoblasts (Fig. 1 A1
inset, arrow) undergo elongation (Fig. 1 A2–A3 insets, ar-
rows) and attach to MTJs (Fig. 1 A2–A3), arrowheads) that
are derived from initial somite boundaries (Fig. 1 A1 , ar-
rowheads). Slow- and fast-twitch muscle fibers are spatially
segregated during zebrafish development [34]. Slow-twitch
muscle fibers are specified medially and then migrate lat-
erally. Slow-twitch muscle fiber migration triggers the elong-
ation of fast-twitch muscle fibers [35]. These morphological
changes are accompanied by molecular changes in the
ECM: laminin increases and Fn is downregulated [9]. At
18 hpf, in segments where slow-twitch muscle migration
has not yet occurred, Fn is present throughout the medial-
lateral extent of the MTJ (Fig. 1B1, see 3D projection and
transverse view (T)). Fn is then downregulated medial to
slow-twitch muscle fibers as they migrate laterally. In other
words, Fn is downregulated at the MTJ adjacent to fast-
twitch fibers after slow-twitch fibers migrate through the
fast-twitch domain. This downregulation results in Fn con-
centrating adjacent to slow-twitch but not fast-twitch
muscle fibers at 24 hpf (Fig. 1B2, arrow). Thus, migrating
slow-twitch muscle fibers provide a spatial and temporal
marker for normal Fn downregulation. By 48 hpf, Fn is de-
tected at relatively low levels throughout the MTJ. Fn con-
centrates at a subset of slow-twitch muscle fibers called
muscle pioneers (MPs) (Fig. 1B3, asterisk in T). The pattern
of laminin-111 accumulation at the MTJ adjacent to fast-
twitch fibers is reciprocal to that of Fn. Laminin-111 depos-
ition at the MTJ increases through 48 hpf (Fig. 1 C1–C3, ar-
rowheads in Fig. 1 C2, C3). The changes in muscle cell
morphogenesis, Fn, and laminin-111 at the MTJ are car-
tooned in Fig. 1D (side view) and Fig. 1E (oblique transverse
view).
Laminin organization is required for Fn downregulation
at the MTJ
The reciprocal regulation of Fn and laminin in the fast-
twitch muscle domain suggests the hypothesis that lam-
inin organization/deposition/signaling acts as a cue/
checkpoint that is permissive for Fn downregulation
(Fig. 2a). If this is the case, absence of laminin at the
MTJ would result in increased levels of Fn. Laminins are
cross-shaped heterotrimeric proteins comprised of an
alpha, beta, and gamma chain. Translated laminin gene
products (one alpha, one beta, and one gamma) self-
assemble into cross-shaped laminin proteins with the
alpha subunit constituting the long arm of the cross and
the beta and gamma subunits forming the short arms of
the cross [36, 37]. Assembled laminin proteins then
polymerize with other laminin proteins and other ECM
molecules to form specialized basement membranes.
Laminin-111 (assembled from laminin alpha1, beta1,
and gamma1 gene products) is the developmental iso-
form of laminin relevant for early muscle development
[30, 38, 39]. We tested the hypothesis that laminin
organization/deposition/signaling acts as a cue/check-
point that is permissive for Fn downregulation by asses-
sing Fn protein levels in laminin beta1 or laminin
gamma1 mutant zebrafish (Fig. 2a). As laminin beta1
and laminin gamma1 gene products are both part of the
assembled laminin-111 protein, neither of these mutant
zebrafish lines will have the laminin-111 isoform or any
other isoform of laminin that utilizes laminin beta1 or
laminin gamma1 gene products, respectively. Protein
immunoblots of whole embryo extracts at 48 hpf showed
increased Fn levels in laminin gamma1 mutants com-
pared to siblings (Fig. 2b). Slow-twitch fiber migration is
slightly delayed in laminin beta1 and gamma1 mutant
embryos but recovers by 26 hpf [40]. Thus, at 32 hpf,
slow-twitch fibers can be used as a marker for Fn: Fn
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Fig. 1 Fn and laminin are reciprocally expressed at the MTJ adjacent to fast-twitch fibers during muscle morphogenesis. A–C Anterior left, dorsal
top, side-mounted, wild-type embryos. Phalloidin staining for actin to visualize the cell morphological changes during muscle morphogenesis. A1 At
16 hpf, muscle precursors are round (arrow in inset) and actin accumulates between somite boundaries (arrowheads). A2 At 24 hpf, muscle cells have
elongated (arrow in inset) and actin continues to accumulate at the boundary (arrowheads). A3 At 48 hpf, muscle fibers have undergone further
growth and become striated (arrow in inset). MTJs are devoid of actin staining (arrowheads). B1–B3 Focal planes, 3D projections (anterior left, dorsal
top, side-mounted), and transverse views ((T) lateral right, dorsal top) of phalloidin (blue) and Fn antibody staining (red). b1 At 18 hpf, Fn accumulates
throughout the medial-lateral extent of the MTJ. B2 At 24 hpf, Fn is adjacent to lateral, superficial slow-twitch fibers (arrowheads in T) as well as medial
MPs (arrow in focal plane and asterisk in T). B3 At 48 hpf, Fn is downregulated throughout the medial portion of the MTJ except adjacent to MPs (asterisk
in T). C1–C3 Focal planes, 3D projections (anterior left, dorsal top, side-mounted), and transverse views ((T) lateral right, dorsal top) of phalloidin (blue)
and laminin-111 antibody staining (green). C1 At 18 hpf, laminin-111 begins to polymerize at the MTJ. C2 At 24 hpf, polymerized laminin-111 is adjacent
to slow- and fast-twitch muscle fibers (arrowhead in focal plane points to laminin-111 adjacent to fast-twitch muscle fibers). C3 At 48 hpf, laminin-111
remains throughout the medial-lateral extent of the MTJ (arrowhead denotes laminin-111 adjacent to fast-twitch muscle fibers). D, E Models of Fn-
laminin dynamics at the MTJ in a medial focal plane (D) and a 3D rendering (E) over developmental time. The presence of slow-twitch fibers (blue) along
the midline confirms that focal planes are medial sections. D1 At 18 hpf, a mainly Fn myomatrix segregates somites. D2–D3 In medial focal planes at 24
and 48 hpf, because slow-twitch fibers have migrated laterally, a mainly laminin-111 myomatrix separates myotomes. E1 As slow-twitch fibers migrate
laterally, myoblasts elongate and the mainly Fn matrix is replaced by a mainly laminin-111 matrix medial to the location of migrating slow-twitch fibers.
E2 After slow-twitch fiber migration is complete, the MTJ is primarily laminin-111 adjacent to fast-twitch fibers while Fn remains adjacent to slow-twitch
fibers. Scale bars are 50 μm
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should be downregulated medial to slow-twitch fibers.
Fn was abnormally abundant throughout the medial-
lateral extent of the MTJ in laminin beta1 or laminin
gamma1 mutants compared to siblings at 32 hpf (com-
pare Fig. 2D to C and Fig. 2F to E). To test whether lam-
inin regulates Fn at the transcriptional level, we assayed
fn1a and fn1b mRNA abundance in laminin gamma1
mutants and their siblings at 26 hpf. Fn1a transcript
abundance was not changed in laminin gamma1 mu-
tants compared to sibling controls; however, fn1b tran-
script abundance was approximately fourfold higher in
laminin gamma1 mutants compared to controls (Fig. 2g,
fn1a: 0.9 +/− 0.2 or 0.9 +/− 0.1 in laminin gamma1 mu-
tants relative to controls normalized to beta-actin or
gapdh, respectively; fn1b: 3.6 +/− 0.5 or 4.1 +/− 0.5 in
laminin gamma1 mutants relative to controls normal-
ized to beta-actin or gapdh, respectively). The fact that
multiple assays—qPCR, Western blotting, and immuno-
cytochemistry—show increased Fn in laminin mutant
embryos supports the hypothesis that laminin is required
for Fn downregulation.
The phenotype of laminin beta1 or laminin
gamma1 mutants is fairly severe: embryos are trun-
cated, somites are much narrower in the anterior-
posterior axis, and muscle fiber elongation is delayed
[41]. We previously showed that Nicotinamide Ribo-
side Kinase 2b (Nrk2b) is required for organized lam-
inin at MTJs during muscle development [31]. The
phenotype of nrk2b morphant embryos is milder than
that of laminin beta1 or laminin gamma1 mutants:
embryos are longer, somites are wider, and neither
development nor muscle fiber elongation is delayed.
We used nrk2b morphants to ask whether Fn remains
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Fig. 2 Organized laminin deposition is required for Fn downregulation. a Hypothesis that laminin deposition regulates Fn downregulation. Upper
panel: laminin is polymerized at the MTJ and Fn is downregulated. Lower panel: laminin deposition/organization is disrupted and Fn perdures at
the MTJ. b Western blot of whole embryo homogenates at 48 hpf using anti-Fn antibody. Laminin gamma1 mutants have approximately 2.5-fold
more Fn compared to siblings. Alpha-tubulin was used as a loading control. (C–F; H–K) Anterior left, dorsal top, side-mounted embryos. Fn anti-
body (red), F59 antibody to label slow-twitch fibers (dark blue), laminin-111 antibody (green), phalloidin staining (light blue). c Medial focal plane of
32 hpf sibling. Note Fn (red) has been downregulated adjacent to fast-twitch fibers. d Medial focal plane of 32 hpf laminin beta1 mutant (n = 16
embryos). Note that Fn persists adjacent to medial, fast-twitch fibers. e Medial focal plane of 32 hpf sibling. Note Fn (red) has been downregulated
adjacent to fast-twitch fibers. f Medial focal plane of 32 hpf laminin gamma1 mutant (n = 28 embryos). Note that Fn persists adjacent to medial,
fast-twitch fibers in laminin beta1 and gamma1 mutant zebrafish. g Relative mRNA abundance of fn1a and fn1b in laminin gamma1 mutants
compared to siblings at 26 hpf (n = 3 biological replicates of at least five embryos each). Fn1a expression is unchanged whereas fn1b expression is
upregulated in laminin gamma1 mutants. h Focal plane of laminin-111 antibody staining in a 24-hpf control embryo. i Focal plane of laminin-111
antibody staining in a 24-hpf nrk2b morphant embryo. Note that laminin-111 protein is present, but that the organization of laminin-111 at MTJs is
disrupted. j Medial focal plane of Fn antibody staining in a 32-hpf control embryo. k Medial focal plane of Fn antibody staining in a 32-hpf nrk2b
morphant embryo (n = 9 embryos). Fn is present at the MTJ adjacent to MPs and fast-twitch fibers in nrk2b morphants. Scale bars are 50 μm
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present, but the organization of laminin-111 at MTJs
is disrupted compared to controls (Fig. 2h, i). In med-
ial focal planes of control embryos at 32 hpf, Fn was
concentrated at the MTJ adjacent to MPs and the
horizontal myoseptum and was not visible at the MTJ
adjacent to fast-twitch muscle fibers (Fig. 2j). Fn was
also concentrated at the MTJ adjacent to medial MPs
in nrk2b morphant embryos at 32 hpf; however, Fn
concentration at the MTJ adjacent to fast-twitch
muscle fibers was much higher in nrk2b morphant
embryos compared to controls at 32 hpf (Fig. 2k). As
stated above, the relative abundance of fn1b tran-
scripts was upregulated in in laminin gamma1 mu-
tants. The relative abundance of fn1b is similarly
upregulated in nrk2b morphants compared to controls
(fn1b: 2.9 +/− 0.6 or 3.3 +/− 1.2 in nrk2b morphants
relative to controls normalized to beta-actin or gapdh,
respectively). Taken together, the above data indicate
that organized laminin, and not just the presence of
laminin protein, is necessary for Fn downregulation
during MTJ development.
Laminin is necessary to recruit/retain Mmp11 at the MTJ
Our data show that increased transcription of fn1b
(Fig. 2g) could explain the persistence of Fn protein at
MTJs in laminin mutants; however, the low level of ex-
pression of fn1a and fn1b mRNA after segmentation is
complete [21, 42] also suggests the possibility that
changes in Fn protein levels at the MTJ may be medi-
ated posttranslationally. Although laminin is necessary
for normal Fn downregulation, laminin itself is not a
candidate for degrading Fn because laminin has not
been shown to have protease activity. Collectively, the
members of the MMP family of proteases are able to de-
grade all proteins found in the ECM [43]. We therefore
looked for MMPs that fit two criteria: (1) MMP “X”
would need to be expressed at the right time and place
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Fig. 3 Normal laminin deposition/organization is necessary for concentration of Mmp11 at MTJs. A1–A3 Anterior left, dorsal top, side-mounted,
wild-type embryos stained with anti-Mmp11 antibody at 20, 26, or 48 hpf, respectively. Note that Mmp11 increasingly concentrates at MTJs (white
arrows) over developmental time. B1, B2 Western blots of whole embryo homogenates at 26 hpf using an anti-Mmp11 antibody. B1 Laminin
gamma1 morphants have approximately 8.5-fold less Mmp11 protein compared to controls. B2 Laminin gamma1 mutants show no change
(approximately 1.2-fold more) Mmp11 protein compared to siblings. (C–E) Side view, anterior left, dorsal top, 27 hpf embryos stained with
phalloidin (light blue), and anti-Mmp11 antibody (purple). C1–C3 Control embryo. Mmp11 localizes to the MTJ (peaks in C3) and is absent from
the myotome (valleys in c3). c3 Histogram of relative pixel intensities across the white rectangle in panel c2. d1–d3 nrk2b morphant. Mmp11 is
expressed and concentrates at MTJ in nrk2b morphants (white arrow in d2 and peaks in d3); however, Mmp11 localization is disrupted as can be
seen by the increased staining within myotomes (higher intensity of valleys in d3 compared to c3) (n = 13 embryos). d3 Histogram of relative pixel
intensities across the white rectangle in panel D2. E1–E3 laminin gamma1 mutant. Mmp11 does not localize to MTJs (absence of clear peaks and
valleys in E3), except in small patches (white arrowhead in E2) (n = 7 embryos). E3 Histogram of relative pixel intensities across the white rectangle
in panel E2. Scale bars are 50 μm
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laminin would need to regulate MMP “X.” The rationale
for the second criteria is that if laminin is required for
Fn downregulation, one potential mechanism would be
that laminin regulates MMP “X” expression, localization,
or activity. Mmp11 (stromelysin-3) is strongly expressed
at the MTJ in zebrafish at 2 days post fertilization [44].
We analyzed Mmp11 expression earlier in muscle devel-
opment and found that Mmp11 was initially distributed
throughout the somitic mesoderm (Fig. 3A1). Mmp11
was more concentrated at the MTJ at 26 hpf (Fig. 3A2)
and was robustly localized to the MTJ at 48 hpf
(Fig. 3A3). Thus, Mmp11 is expressed in the right time
and place to play a role in Fn downregulation.
We next asked if laminin deposition/organization is
necessary for Mmp11 expression by analyzing Mmp11
protein levels in laminin-deficient embryos. Mmp11 pro-
tein levels were decreased in whole embryo homoge-
nates of laminin gamma1 morphant embryos compared
to controls at 26 hpf (Fig. 3B1); however, overall Mmp11
protein levels were unchanged in whole embryo homog-
enates of 26 hpf laminin gamma1 mutants compared to
siblings (Fig. 3B2). This discrepancy could be due to the
function of maternally provided laminin gamma1 in the
mutants. Laminin gamma1 is maternally expressed [30].
The phenotype of morphants is sometimes more severe
than mutants because morpholinos can block translation
of both maternal and zygotic transcripts [45]. Therefore,
laminin gamma1 morphants and mutants would both
lack zygotic laminin gamma1 protein. In contrast, mu-
tants would express maternal laminin gamma1 protein
but morphants would not. The reduction in Mmp11
levels in laminin gamma1 morphants could be a non-
specific artifact of morpholino knockdown technology or
the maternally supplied laminin gamma1 in laminin
gamma1 mutants could be sufficient for normal Mmp11
expression through primary muscle development.
As the effect of laminin on Mmp11 was not clear from
Western analysis, we performed immunocytochemistry to
visualize Mmp11 localization in embryos with disrupted
laminin-111 at MTJs. Control, mutant, and morphant im-
ages were imaged with the same settings and post-
processed identically with Photoshop. In control embryos
at 27 hpf, Mmp11 was strongly concentrated at MTJs
(Fig. 3 C1, C2). A histogram of relative pixel intensities
across the white rectangle in Fig. 3C2 corroborates that
Mmp11 localized to MTJs: tall, tight peaks of bright pixel
intensities occurred at MTJs and low valleys between
peaks represent dim pixel intensities throughout myo-
tomes. We used nrk2b morphants, where laminin at the
MTJ is significantly less organized, to ask whether laminin
organization regulates Mmp11 localization. Mmp11 con-
centrated at the MTJ in nrk2b morphants (Fig. 3 D1, D2,
white arrow); however, Mmp11 was also observed
throughout the myotome (Fig. 3D2). In the histogram of
relative pixel intensities, tall peaks of bright pixel inten-
sities occurred at MTJs (Fig. 3D3), supporting the obser-
vation that Mmp11 localized to MTJs in nrk2b
morphants. However, pixel intensities between peaks were
higher in nrk2b morphants compared to controls (Fig. 3
C3, D3). This reflects the observation that more Mmp11
localized within the myotome in nrk2b morphants than
controls. Mmp11 concentration at the MTJ was even
more disrupted in laminin gamma1 mutant embryos.
Mmp11 only concentrated at MTJs in small patches
(Fig. 3E2, arrowhead), and the histogram of relative pixel
intensities showed wide, irregular peaks, and high pixel in-
tensities within myotomes (Fig. 3(E3)). These data suggest
that laminin adhesion and/or signaling modulate Mmp11
localization.
Mmp11 is necessary and sufficient for Fn downregulation
The above data indicate that laminin is necessary for
both Mmp11 localization to the MTJ and Fn downregu-
lation at the MTJ. Therefore, Mmp11 cleavage of Fn
could be a mechanism through which laminin promotes
downregulation of Fn at the MTJ. However, MMP11
shows only weak protease activity against Fn in vitro
[46]. As in vivo functions for Mmp11 are not fully eluci-
dated, Mmp11 could directly or indirectly modulate Fn
levels at the MTJ. We used a reverse genetics approach
to knockdown Mmp11 protein levels and assay the effect
on Fn. The human MMP11 (ST-3) gene has two zebra-
fish paralogs, mmp11a and mmp11b [44], so we de-
signed translation-blocking morpholinos (MOs) against
both. Injection of either MO alone did not appreciably
reduce Mmp11 expression on immunoblots of whole
embryo homogenates; however, co-injection of both
MOs dramatically decreased Mmp11 levels (Fig. 4A).
We therefore co-injected mmp11a and mmp11b MOs in
all subsequent experiments.
Injection of mmp11 MOs did not overtly affect body,
slow-twitch muscle, or fast-twitch muscle morphology
compared to control embryos (Fig. 4B, C and data not
shown). We used mmp11 morphants to ask whether
Mmp11 is required for Fn downregulation. We found Fn
protein to be increased in whole embryo homogenates of
mmp11morphants compared to controls (Fig. 4D). The in-
crease in Fn was also apparent with immunostaining. In
control embryos, Fn was downregulated medial to migrat-
ing slow-twitch muscle fibers, resulting in very little Fn at
the MTJ adjacent to fast-twitch muscle fibers (Fig. 4E1,
E1’). In contrast, Fn remained at the MTJ adjacent to slow-
twitch and fast-twitch fibers in mmp11 morphants
(Fig. 4E2, E2’, arrowhead and arrow, respectively). Thus,
multiple types of analysis—western blotting and whole
mount immunocytochemistry—show increased Fn levels
in mmp11 morphants. The fact that embryonic develop-
ment is grossly normal in mmp11 morphant embryos
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suggests that the requirement of Mmp11 for Fn downregu-
lation is specific and not due to confounding requirements
for Mmp11 during early development. Taken together,
these data suggest that Mmp11 is necessary for normal
downregulation of Fn during muscle development.
We next asked whether Mmp11 is sufficient to
downregulate Fn. We found that ubiquitous overex-
pression of Mmp11 during early development dis-
rupted morphogenesis (data not shown). We therefore
expressed Mmp11 under control of the heat shock
promoter to allow for control over the timing of
Mmp11 overexpression. Embryos were injected with
the Tg(HSP:mmp11-EGFP) construct and tol2 transpo-
sase mRNA at the one-cell stage, grown at normal
temperature, and then heat-shocked at 18 hpf. At
5 hours post-heat shock, transient overexpression of
Mmp11 resulted in decreased levels of Fn compared
to controls on immunoblots from whole embryo
lysates (Fig. 4D). In embryos derived from matings of
the stable Tg(HSP:mmp11-EGFP) line, Mmp11-EGFP
expression was observed throughout the myotome
and concentrated at MTJs (Fig. 4E3). Fn immuno-
staining revealed reduced Fn throughout the MTJ,
even in the muscle pioneer domain, compared to
controls (Fig. 4E3’). The effects of ectopic Mmp11 on
Fn levels were even more pronounced in mmp11
morphants. In mmp11 morphants that express ectopic
Mmp11-EGFP, Fn was drastically reduced at the MTJ
compared to mmp11 morphant controls (Fig. 4E4,
E4’). These data indicate that Mmp11 overexpression
is sufficient to downregulate Fn at the MTJ. Further-
more, as Mmp11 expression rescues the mmp11 mor-
phant phenotype, this experiment provides evidence
that mmp11 MOs are specific and suggests that the
aberrant upregulation of Fn seen in mmp11 mor-







































Fig. 4 Mmp11 is necessary and sufficient for Fn downregulation. A Western blot of whole embryo homogenates at 26 hpf using Mmp11
antibody. Injection of individual MOs (a or b) alone did not reduce Mmp11 protein levels compared to controls. Co-injection of both MOs (a + b)
reduced Mmp11 levels by approximately 14-fold compared to controls. Alpha-tubulin was used as a loading control. B, C Focal planes, 3D projections
(anterior left, dorsal top, side-mounted), and transverse views ((T) lateral left, dorsal top) of control embryo (B) and mmp11 morphant (C) at 27 hpf, fast
muscle fibers are stained with phalloidin (light blue) and slow-twitch fibers are stained with F59 (white). D Western blot of whole embryo homogenates
at 32 hpf (upper panel) or 23 hpf (lower panel) using anti-Fn antibody. Upper panel: Fn protein level is increased by approximately 4.7-fold in mmp11
morphants compared to controls. Lower panel: Fn protein level is decreased by approximately 4.2-fold in embryos overexpressing mmp11-EGFP (tTg)
compared to controls. E Medial focal plane, anterior left, dorsal top, side-mounted embryos at 26 hpf stained with Fn antibody (red) and F59 antibody
(blue). Overexpression of mmp11-EGFP is green. E1, E1’ Control. (E2–E2’) mmp11 morphant (n > 60 embryos). Note that Fn concentrates adjacent to
MPs in both controls and mmp11 morphants (arrowheads in E1’ and E2’) but only concentrates adjacent to fast-twitch muscle fibers in mmp11 morphants
(arrow E2’). E3–E3’ mmp11-EGFP transgenic. Note that Fn is downregulated adjacent to MPs in transgenics compared to controls. E4–E4’ mmp11 morphant
overexpressing mmp11-EGFP (n> 50 embryos). Mmp11-EGFP overexpression reduced Fn levels throughout the MTJ in mmp11 morphants. Scale bars
are 50 μm
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Laminin functions upstream of Mmp11 in the regulation
of Fn at MTJs
The data presented thus far fit a unidirectional model
where laminin is necessary for localization of Mmp11 to
MTJs, and Mmp11 is then necessary and sufficient for
the regulation of Fn. As many regulatory networks in-
volve bidirectional signaling interactions, it is also pos-
sible that Mmp11 regulates laminin and laminin, in turn,
affects Fn levels at MTJs. To investigate this possibility,









Fig. 5 Laminin-111 at MTJs in not affected by Mmp11 knockdown or overexpression. A–F1, H–K1 Anterior left, dorsal top, side-mounted embryos
stained for laminin-111 (green), nuclei (light blue), actin (light or dark blue), beta-dystroglycan (orange), or showing Mmp11-GFP (purple). A–B laminin-111
antibody and nuclei staining in 26 hpf embryos. A Control embryo. B mmp11 morphant embryo. C–D laminin-111 antibody and phalloidin staining in
48 hpf embryos. C Control embryo. D mmp11 morphant embryo (n= 8 embryos). Note that laminin-111 appears normal in mmp11 morphants compared
to controls at 26 and 48 hpf. E–F1 Beta-dystroglycan antibody and phalloidin staining in 27 hpf embryos. E, E1 Control embryo showing merged panel
E and beta-dystroglycan antibody staining alone (E1). F, F1 mmp11 morphant embryo showing merged panel F and beta-dystroglycan antibody staining
alone (F1). Normal beta-dystroglycan antibody staining in mmp11 morphants indirectly supports that laminin-111 is unaffected by Mmp11 knockdown.
G Relative mRNA abundance of lama1, lama2, lamb1, and lamc1 in mmp11 morphants compared to controls at 26 hpf. The expression of the laminin
genes assayed is unchanged by Mmp11-GFP overexpression (n= 2 biological replicates of at least five embryos each). H–K1 laminin-111 antibody and
phalloidin staining in heat-shocked AB controls and Tg(HSP:mmp11-GFP) embryos. H Control embryo at 26 hpf showing laminin-111 and laminin-111
merged with phalloidin (inset). I, I1 26 hpf Tg(HSP:mmp11-GFP) embryo showing laminin-111 (I), laminin-111 merged with phalloidin and Mmp11-GFP (inset
in I), Mmp11-GFP (I1), and Mmp11-GFP merged with laminin-111 (inset in I1). J Control embryo at 48 hpf showing laminin-111 and laminin-111 merged
with phalloidin (inset). K, K1 48 hpf Tg(HSP:mmp11-GFP) embryo showing laminin-111 (K), laminin-111 merged with phalloidin and Mmp11-GFP (inset in K),
Mmp11-GFP (K1), and Mmp11-GFP merged with laminin-111 (inset in K1). Note that the timing of Mmp11-GFP MTJ localization recapitulates that of native
Mmp11 protein, Mmp11-GFP and laminin-111 co-localize at MTJs, and laminin-111 appears normal in Tg(HSP:mmp11-GFP) embryos (n= 5 embryos). Scale
bars are 50 μm
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mmp11 morphants and/or transgenics that overexpress
Mmp11. Deposition of laminin-111 protein at MTJs
in mmp11 morphants was similar to controls at both
24 and 48 hpf (Fig. 5A–D). Furthermore, antibody stai-
ning for beta-dystroglycan (part of the dystrophin-
glycoprotein complex receptor for laminin-111) in
27 hpf mmp11 morphants compared to controls was
also similar (Fig. 5E–F1). This result supports the obser-
vation that laminin-111 deposition is unaffected in
mmp11 morphants.
Next, we analyzed mRNA expression of laminin genes
and laminin-111 protein localization in zebrafish stably
overexpressing Mmp11-GFP. Expression of relevant
laminin gene products for the isoforms of laminin
expressed in skeletal muscle development and homeo-
stasis (i.e., laminin alpha1, alpha2, beta1, and gamma1)
was not changed in 26 hpf Tg(HSP:mmp11-GFP) em-
bryos compared to heat-shocked AB controls (Fig. 5G).
Additionally, laminin-111 deposition and localization at
MTJs appeared normal at 26 and 48 hpf in embryos
overexpressing Mmp11-GFP (Fig. 5H, I and Fig. 5J, K,
respectively). The expression and localization of
Mmp11-GFP recapitulated that of the endogenous pro-
tein: Mmp11-GFP began to localize to MTJs at 26 hpf and
was robustly localized to MTJs by 48 hpf (Fig. 5 I1, J1,








mutant; mmp11 MOsmutant control












laminin 1 mutant; mmp11 MOslaminin 1
Fibronectin Fibronectin F59 
A A1 B B1
C C1 D D1
Fig. 6 Injection of mmp11 MOs increases Fn at the 48 hpf MTJ in laminin gamma1 mutants and improves slow-twitch fiber morphology. A–D
Anterior left, dorsal top, side-mounted, 3D projections of embryos stained for slow-twitch fibers with F59 antibody (blue) and Fn antibody (red).
A 32 hpf laminin gamma1 mutant. B 32 hpf laminin gamma1 mutant; mmp11 morphant. C 48 hpf laminin gamma1 mutant. D 48 hpf laminin
gamma1 mutant; mmp11 morphant. Note that in 48 hpf laminin gamma1 mutants, Fn is not clearly concentrated at MTJs (C, n = 14 embryos). In
contrast, Fn robustly concentrates at MTJs in laminin gamma1 mutants injected with mmp11 morpholinos at 48 hpf (D, n = 8 embryos). E–H
Anterior left, dorsal top, side-mounted, 3D projections of embryos stained with anti-F59 antibody. Small inset boxes are brightfield, whole mount,
live images. E laminin gamma1 mutant at 24 (inset) or 32 hpf. F laminin gamma1 mutant injected with mmp11 MOs at 24 (inset) or 32 hpf. Note
that overall body shape and slow-twitch muscle fibers are similar in both mutants and mutant morphants at 24 and 32 hpf. G laminin gamma1
mutant at 72 hpf. H laminin gamma1 mutant injected with mmp11 MOs at 72 hpf. Slow-twitch muscle fiber detachment can be clearly seen in
laminin gamma1 mutant embryos at 72 hpf. However, laminin gamma1 mutants injected with mmp11 MOs have less fiber detachment at this
time point
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were found to co-localize at MTJs in Tg(HSP:mmp11-
GFP) embryos at 26 and 48 hpf (Fig. 5 I1, J1 insets). This
result suggests that laminin-111 deposition was unaffected
by Mmp11 overexpression. Therefore, laminin-111 regu-
lates Mmp11 localization to MTJs but not vice versa. This
suggests that laminin is upstream of Mmp11 in the regula-
tion of Fn. Although our data do not rule out the possibil-
ities of bidirectional or non-linear signaling, they do
suggest that laminin-111 functions upstream of Mmp11
in this context.
Fn levels correlate with phenotypic severity of laminin
mutants
We showed that laminin is required for normal Mmp11
expression and Fn levels at the MTJ: in the absence of
laminin, Fn levels are increased and Mmp11 levels are
decreased. Interestingly, the perdurance of Fn at the
MTJ laminin gamma1 mutants is transient. Increased
Fn was clear at 32 hpf (Fig. 6A) but Fn was not observed
in mutant MTJs at 48 hpf (Fig. 6C). Injection of mmp11
MOs into laminin gamma1 mutants resulted in the ex-
pected persistence of Fn at the MTJ at 32 hpf (Fig. 6B)
but strikingly, Fn persisted in morphant/mutants even at
48 hpf (Fig. 6D). We next tested whether prolonging the
transient increase in Fn at MTJs in laminin mutants had
any effect on the laminin mutant phenotype by injecting
mmp11 MOs into laminin gamma1 mutant zebrafish.
Neither the whole embryo morphology nor the slow-
twitch muscle of laminin mutants appeared different from
mutant morphants at 24 or 32 hpf (Fig. 6E–F). By 72 hpf,
slow-twitch muscle fibers had degenerated and could be
visualized as spheres instead of cylindrical fibers in lam-
inin mutants (Fig. 6G). Slow-twitch muscle fiber degener-
ation was drastically reduced in laminin gamma1 mutants
injected with mmp11 MOs compared to mutant controls
(Fig. 6H). Thus, Mmp11 knockdown can partially com-
pensate for the muscle defects seen in laminin gamma1
mutants, likely via prolonging the presence of Fn at the
MTJ. These data suggest that, in the absence of laminin,
the amount of Fn has a significant effect on the rate and
amount of muscle degeneration. All together, we find that
myomatrix crosstalk between laminin and Fn regulates
Mmp11-dependent remodeling of zebrafish MTJs during
development and that this remodeling can be manipulated
to improve muscle tissue structure.
Discussion
The ECM is an essential component of metazoan tissues
and exhibits extraordinary complexity and dynamics at a
molecular level. The delicate balance between the deg-
radation and deposition of ECM constituents is con-
stantly changing, and its regulation is central to normal
development and tissue homeostasis. Thus, it is not sur-
prising that misregulation of ECM remodeling plays a
role in aging and disease. ECM components are regu-
lated on many different levels: regulation of transcription
(including alternate splicing and miRNA-mediated silen-
cing), translation, protein trafficking, posttranslational
modifications, and formation of multiprotein complexes.
Most of what is known about ECM remodeling is based
on in vitro studies, and a current challenge is to relate
these insights to in vivo processes. Towards this end, we
investigated mechanisms of Fn downregulation during
MTJ development. We show that one initial cue for Fn
downregulation is organized deposition of a different
ECM protein, laminin. Laminin downregulates fn1b
transcription and potentiates Mmp11 localization to the
MTJ. Mmp11 is then both necessary and sufficient for
Fn downregulation (Fig. 7). Therefore, we have eluci-
dated a novel regulatory pathway that mediates Fn
downregulation in vivo.
Mmp11: a critical regulator of Fn levels in vivo
The matrix metalloproteinases (MMPs) cleave all known
ECM proteins. MMPs are tightly regulated during devel-
opment and homeostasis, and changes in MMP expres-
sion occur in many diseases [27, 28]. For example,
several MMPs were originally identified because of their
upregulation in cancer cell lines. Stromelysin-3 (MMP11
in mammals or Mmp11 in zebrafish) is over expressed
in several cancers, where its abundance correlates with
tumor aggressiveness and concomitant mortality rates
[47–49]. Specifically, increased levels of MMP11 in hu-
man and mouse breast cancers are associated with in-
creased metastasis and poor patient prognosis [49–53].
Multiple lines of evidence suggest that MMP11 is a pro-
tein with important functions in normal development as
well as disease. MMP11 expression is found in remodel-
ing ECM and is required for cell migration during nor-
mal morphogenesis in Xenopus [54]. Here, we show that
(1) Mmp11 protein localizes to the MTJ during myogen-
esis in a laminin-dependent manner, (2) Mmp11 is ne-
cessary and sufficient for Fn downregulation at the MTJ,
and (3) inhibiting Mmp11 activity in laminin mutants
increases Fn levels and improves muscle structure. Thus,
our data extend and support previous experiments indi-
cating that Mmp11 plays crucial roles in morphogenesis.
The data shown here do not resolve whether Mmp11
degrades Fn in vivo directly or indirectly due to tech-
nical limitations. MMP11 shows weak protease activity
against Fn in vitro [46]. However, it remains largely un-
determined whether the ability or inability of MMPs to
cleave substrates in vitro corresponds with their in vivo
activities. It is possible that MMP11 cleaves Fn in vivo
more efficiently, perhaps due to mechanical load on the
Fn fibrils, contractile forces, or other interactions that
position scissile bonds such that they become accessible
to the protease. It is also possible that the effects of
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MMP11 on Fn are indirect. MMP11 is activated intracel-
lularly by Furin [55] and is capable of cleaving and activat-
ing both extracellular and intracellular proteins, such as
proMMPs [56]. Therefore, MMP11 may have indirect ef-
fects on Fn downregulation by activating other proteases.
Recently, it has been shown that Mmp14a is expressed at
the zebrafish MTJ at 24 and 48 hpf [57], which makes it a
good candidate to be involved in the regulation of Fn.
MMP14 is known to degrade Fn [58] and is critical for
myoblast differentiation in vitro [59]. In addition, MMP11
is a MMP14 substrate and MMP14 thereby negatively reg-
ulates MMP11 [60]. Interactions between MMP11,
MMP14, laminin, and Fn will be interesting to identify in
future studies. Alternatively, MMP11 could affect Fn levels
indirectly via MMP11-dependent regulation of receptors
for laminin. MMP11 cleaves the 67kD non-integrin lam-
inin receptor (LR) in vivo [61, 62]. It is possible that
MMP11 does not directly degrade Fn but rather releases
LR-mediated inhibition of some other protease. Regard-
less, our data clearly show that Mmp11 is necessary and
sufficient for Fn downregulation in vivo. It will be interest-
ing in the future to identify molecular mechanisms under-
lying this ECM remodeling, such as the mechanisms of
Mmp11 action and the effect of ectopic Mmp11 in disease
states associated with excess Fn (i.e., fibrosis).
Fn levels are dynamically regulated in development and
disease
Fn plays important roles in development, repair/regener-
ation, and the transition to disease states in many organs.
Fn is required for mesoderm specification, left-right pat-
terning, trunk elongation, angiogenesis, heart morphogen-
esis, and migration of myocardial cells [21, 63–69]. In
skeletal muscle, Fn is required for muscle development
[22, 42, 70] and is both necessary and sufficient in the
stem cell niche for muscle regeneration [5]. However, up-
regulation of Fn, while critical for certain developmental
processes, is also linked to tumor metastasis and fibrosis.
Fn is upregulated in many cancers and promotes forma-
tion of the premetastatic niche, which generates a
microenvironment more hospitable for tumor cell adhe-
sion and proliferation [71–74]. Fibrosis, the aberrant de-
position of Fn and various collagens, diminishes organ
function. Inhibiting Fn deposition not only prevents but
can reverse liver fibrosis, possibly via both reducing cell
infiltration and not providing a scaffold for collagen de-
position [75]. Fibrosis occurs in skeletal muscle during
aging, atrophic conditions, and disease. Fn is a serum bio-
marker for Duchenne muscular dystrophy, suggesting that
excess Fn contributes to muscle pathology [76]. Thus, the
importance of precise Fn regulation for skeletal muscle
development, regeneration, and function is mirrored in
other organ systems. While these multifactorial roles for
Fn demonstrate the importance of dynamically regulating
Fn levels, the molecular mechanisms regulating Fn ex-
pression and polymerization are just beginning to be elu-
cidated and exceedingly little is known about how Fn is
degraded in vivo. Fn downregulation during development
is a normal part of the transition to a laminin-rich base-
ment membrane at the myotendinous junction (MTJ).
Our data show that laminin, via subcellular localization of
Mmp11 and inhibition of fn1b transcription, is necessary
for Fn downregulation. While likely an indirect effect of
Mmp11, our data implicate Mmp11 and laminin in a
novel network that regulates Fn downregulation in vivo.
As Fn is dynamically regulated in other systems, such as
its degradation behind migrating myocardial cells [21], it
will be interesting to determine if there is a similar regula-
tion of Fn by laminin in other developmental, cell migra-
tory, and/or disease contexts.
Crosstalk between myomatrix proteins and cellular
adaptation in development and disease
Our data provide compelling evidence that there is
crosstalk between the ECM proteins Fn and laminin
during muscle development and that this crosstalk re-
sults in cellular adaptations that protect muscle struc-
ture when development is disrupted. We previously
showed an inverse expression pattern of Fn and laminin
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Fig. 7 Mechanism of in vivo Fn downregulation at the MTJ. Upper panel: normal scenario—laminin is polymerized at the MTJ, Mmp11 expression
is localized at the MTJ, and Fn is subsequently downregulated. Lower panel: scenario when laminin deposition/organization is disrupted—Mmp11
expression is reduced, Mmp11 localization is abnormal, and Fn perdures at the MTJ
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laminin is polymerized adjacent to fast-twitch muscle fi-
bers as they elongate and attach to the MTJ [9]. Here,
we show that laminin deposition/organization acts as a
“checkpoint” for Fn downregulation. To our knowledge,
this is an unrecognized interaction between Fn and lam-
inin and represents a novel paradigm in which laminin
is permissive for Fn downregulation. In a developmental
context, such a mechanism ensures that an established
matrix is continuously present, while simultaneously
permitting biochemical and structural remodeling.
Crosstalk between ECM molecules Fn and Collagen1
has been shown to regulate MMP expression in vitro.
Exogenous Fn caused human fibroblasts to upregulate
MMP15 and MMP9, and subsequent addition of Colla-
gen1 to the Fn-rich matrix attenuated this response [77].
Thus, there appears to be crosstalk between these ECM
molecules as well as between these ECM molecules and
enzymes that remodel ECM. It will be an interesting
line of future investigation to look at such interactions
in vivo as well as to elucidate roles for collagen mole-
cules in normal and pathological remodeling of the
myomatrix.
The crosstalk between laminin and Fn presented here
is reminiscent of the crosstalk between receptors for
ECM proteins that occurs and can be beneficial in
muscle diseases. Adhesion of muscle fibers to the
laminin-rich basement membrane (BM) is critical for
muscle development and homeostasis. Many muscular
dystrophies, including Duchenne, Becker, and Congeni-
tal muscular dystrophy with integrin alpha7 deficiency,
result from mutations that disrupt adhesion of muscle fi-
bers to their BM. There are two main receptor com-
plexes that anchor muscle cells to the BM: the
dystrophin-glycoprotein complex (DGC) and integrin-
based adhesions. Although both of these receptors have
unique functions [78], they can partially compensate for
each other in adhesion to laminin. The fact that patients
with Duchenne muscular dystrophy (DMD), which af-
fects a member of the DGC, show increased expression
of integrin alpha7 [79], highlights the intrinsic crosstalk
between cell-ECM adhesion complexes that occurs in
diseased muscle.
Cell-ECM adhesion complexes sense multiple types of
physiological changes and interface with every major sig-
naling pathway. Thus, cell-ECM adhesion complexes are
ideally situated to facilitate appropriate responses to
physiological change. One approach towards elucidating
the roles of cell-ECM crosstalk in cellular adaptation is
to investigate the dynamic regulation of cell-ECM adhe-
sion during embryonic development. We focus on zebra-
fish MTJ development as a model of in vivo cell-ECM
adhesion and cell adaptation because muscle tissue is
strikingly adaptable. While the increased Fn at the MTJ
of laminin gamma1 mutants did not completely rescue
muscle morphogenesis in these mutants, just as the in-
creased integrin alpha7 expression observed in humans
with DMD does not prevent muscle atrophy, one key
experiment shows that reducing Fn downregulation in
laminin mutants did have a positive effect on slow-
twitch muscle fibers. Injection of mmp11 MOs into lam-
inin gamma1 mutants increased Fn abundance and
decreased slow-twitch muscle degeneration. These data
support the hypothesis that reciprocal regulation of
ECM proteins plays a role in cell adaptation in adverse
conditions (such as the absence of laminin-111 in lam-
inin gamma1 mutants) and suggests that this line of
investigation (elucidating mechanisms of cell-ECM ad-
hesion that regulate cell adaptation during development)
can potentially be translated into meaningful therapies
for certain diseases.
Conclusions
We have addressed the regulatory mechanism of Fibro-
nectin downregulation during MTJ development in vivo.
Our data show that normal laminin organization acts as
a “checkpoint” for Fn downregulation. Furthermore,
laminin signaling modulates both the expression of fn1b
and localization of Mmp11 to MTJs. The augmentation
of Fn at MTJs in mmp11 morphants was reversed by
driving overexpression of Mmp11-GFP, demonstrating
that Mmp11 is both necessary and sufficient for Fn
downregulation (and the specificity of our morpholinos).
Overall, we identify a new mechanism in the myomatrix
that regulates the remodeling process during morpho-
genesis in vivo, and that may be profitably targeted in
the many pathological conditions in which Fn is dysreg-
ulated, to improve muscle tissue structure.
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